All the news Showing 10 of 15 articles from: Prognosis and disease progressionGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources What support do people with liver cirrhosis and their families need? Keith Alcorn / 09 October 2018 People with liver cirrhosis and their families need more information about their condition and prognosis and greater access to palliative care, a systematic review of studies on the needs of people with cirrhosis ... Deaths from end-stage liver disease due to HCV fall in United Kingdom Keith Alcorn / 22 August 2018 Deaths from end-stage liver disease and liver cancer caused by hepatitis C in the United Kingdom fell by 11% in 2017, provisional figures from Public Health England released on 28 July show. Most ... Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection Michael Carter / 03 October 2017 Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection, French investigators report in the ... Results of US research suggest all people with chronic HCV need treatment to reduce mortality risk Michael Carter / 22 March 2017 All people with chronic hepatitis C virus (HCV) infection should start therapy with direct-acting antivirals, research published in the online edition of Clinical Infectious Diseases suggests. Investigators from the United States found that individuals ... Inexpensive interventions can boost engagement with key stages of viral hepatitis care continuum Michael Carter / 14 October 2016 Several cheap interventions can significantly boost engagement with the continuum of care for viral hepatitis, a systematic literature review and a series of meta-analyses published in The Lancet Infectious Diseases show. Programmes led by ... HCV mortality rates in US increased significantly between 2003 and 2013 Michael Carter / 15 March 2016 There was a significant increase in hepatitis C virus (HCV)-related mortality in the United States between 2003 and 2013, investigators report in the online edition of Clinical Infectious Diseases. Each year, there was ... Another study confirms detrimental effects of delaying hepatitis C treatment Liz Highleyman / 05 May 2015 Deferring antiviral therapy for hepatitis C until a person progresses to advanced liver disease has clear drawbacks including lower treatment effectiveness and an increased risk of clinical events and death, according to ... Progression to severe fibrosis or cirrhosis is common among baby boomers with hepatitis C in the US Liz Highleyman / 05 March 2015 The burden of hepatitis C virus (HCV) infection is high in the US, with a substantial number of individuals born between 1945 and 1965 having advanced fibrosis or cirrhosis and therefore being at ... Many hepatitis C patients with cirrhosis or advanced fibrosis face liver failure and liver cancer Liz Highleyman / 07 January 2015 Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within five years, and 23% and 11%, respectively, died, according to a study presented ... Sustained virological response to hepatitis C treatment reduces mortality, liver cancer and liver transplants Liz Highleyman / 10 November 2014 People who achieve sustained virological response (SVR) when treated with interferon-based therapy for hepatitis C have a lower risk of death, are less likely to develop liver cancer and need fewer liver transplants ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive